VKTX Competitors & Alternatives
Compare Viking Therapeutics Inc with similar stocks in the same industry
Biotechnology
VKTX
Main Stock$30.12
Tradestie Score
57
Market Cap
$3.08B
Analyst Upside
+214.8%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$139.15
|
$3.98B | 136.8 | 66 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$107.37
|
$3.91B | - | 55 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$23.76
|
$3.83B | - | 58 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$15.09
|
$3.68B | - | 60 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$82.25
|
$3.67B | - | 46 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$9.97
|
$3.59B | 14.3 | 34 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$19.94
|
$3.58B | 9.0 | 62 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$304.19
|
$3.49B | 32.1 | 44 | Compare |
More VKTX Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry